Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naturopathic Medicine in Neoadjuvant Breast Cancer
NCT02486796Phase 2Terminated
- Sponsor
- City of Hope Chicago
- Start
- Feb 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ganoderma lucidum, coenzyme q10, melatonin in breast cancer, sponsored by City of Hope Chicago. Started Feb 2016; status: terminated.
02
Drugs
ganoderma lucidumcoenzyme q10melatonin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02486796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02486796.